Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- ChecktodayChange DetectedNo substantive content changes detected; the study’s core details remain the same.SummaryDifference0.0%

- Check7 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This change is a metadata update and does not affect the study information presented on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedFallopian tube cancer was added to the Conditions list, expanding the study’s scope. The page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Revision: v3.4.1. Removed the prior notices related to government funding lapse and Revision: v3.4.0.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a Show glossary option on the study page to improve access to defined terms. Metadata changes include addition of 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with corresponding removals/renaming elsewhere.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This is a versioning update with no substantive changes to the study record.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.